Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Mills, C. Soh, C. Rose, S. Cheung, S. Zhao, G. Parker, A. Jackson (2010)
Candidate Biomarkers of Extravascular Extracellular Space: A Direct Comparison of Apparent Diffusion Coefficient and Dynamic Contrast-Enhanced MR Imaging—Derived Measurement of the Volume of the Extravascular Extracellular Space in Glioblastoma MultiformeAmerican Journal of Neuroradiology, 31
M. Aghi, P. Gaviani, J. Henson, T. Batchelor, D. Louis, F. Barker (2005)
Magnetic Resonance Imaging Characteristics Predict Epidermal Growth Factor Receptor Amplification Status in GlioblastomaClinical Cancer Research, 11
K. Corey, Goldman, Jin Kim, Wai-Lee Wong, Vickie King, Tommy, Brock, G. Gillespie (1993)
Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology.Molecular biology of the cell, 4 1
C. Çallı, O. Kitis, N. Yunten, T. Yurtseven, Ş. Işlekel, T. Akalın (2006)
Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.European journal of radiology, 58 3
P. Schaefer, P. Grant, R. González (2000)
Diffusion-weighted MR imaging of the brain.Radiology, 217 2
R. Stupp, Warren Mason, M. Bent, M. Weller, B. Fisher, M. Taphoorn, K. Bélanger, A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, Robert Janzer, Samuel Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J. Cairncross, E. Eisenhauer, R. Mirimanoff (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.The New England journal of medicine, 352 10
Meng Law, Robert Young, James Babb, Erica Pollack, Glyn Johnson (2007)
Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas.AJNR. American journal of neuroradiology, 28 4
A. Lal, Chad Glazer, H. Martinson, H. Friedman, G. Archer, J. Sampson, G. Riggins (2002)
Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion.Cancer research, 62 12
H. Ohgaki, P. Kleihues (2007)
Genetic pathways to primary and secondary glioblastoma.The American journal of pathology, 170 5
A. Franovic, C. Holterman, Josianne Payette, Stephen Lee (2009)
Human cancers converge at the HIF-2α oncogenic axisProceedings of the National Academy of Sciences, 106
J. Steinbach, A. Klumpp, H. Wolburg, M. Weller (2004)
Inhibition of Epidermal Growth Factor Receptor Signaling Protects Human Malignant Glioma Cells from Hypoxia-Induced Cell DeathCancer Research, 64
S. Wetzel, S. Cha, G. Johnson, Peter Lee, M. Law, D. Kasow, Sean Pierce, X. Xue (2002)
Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study.Radiology, 224 3
P. Wachsberger, Y. Lawrence, Yi Liu, B. Daróczi, Xia Xu, A. Dicker (2012)
Epidermal growth factor receptor expression modulates antitumor efficacy of vandetanib or cediranib combined with radiotherapy in human glioblastoma xenografts.International journal of radiation oncology, biology, physics, 82 1
R. Jain, L. Poisson, J. Narang, D. Gutman, L. Scarpace, Scott Hwang, C. Holder, M. Wintermark, R. Colen, J. Kirby, J. Freymann, D. Brat, C. Jaffe, T. Mikkelsen (2013)
Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers.Radiology, 267 1
S. Pietro, ia Mazzoleni, L. Politi, Mauro Pala, Manuela Cominelli, A. Franzin, Sergio Sergi, A. Falini, M. Palma, A. Bulfone, L. Poliani, R. Galli (2010)
Cancer esearch cular and Cellular Pathobiology ermal Growth Factor Receptor Expression Identifies ctionally and Molecularly Distinct Tumor-Initiating Cells uman Glioblastoma Multiforme and Is Required R Gliomagenesis
Ajay Gupta, A. Omuro, A. Shah, J. Graber, W. Shi, Zhigang Zhang, R. Young (2012)
Continuing the search for MR imaging biomarkers for MGMT promoter methylation status: conventional and perfusion MRI revisitedNeuroradiology, 54
I. Mellinghoff, Maria Wang, I. Vivanco, D. Haas-Kogan, Shaojun Zhu, Ederlyn Dia, K. Lu, K. Yoshimoto, Julie Huang, D. Chute, B. Riggs, S. Horvath, L. Liau, W. Cavenee, P. Rao, R. Beroukhim, R. Beroukhim, R. Beroukhim, T. Peck, T. Peck, T. Peck, Jeffrey Lee, Jeffrey Lee, Jeffrey Lee, W. Sellers, W. Sellers, W. Sellers, D. Stokoe, M. Prados, T. Cloughesy, C. Sawyers, P. Mischel (2005)
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.The New England journal of medicine, 353 19
R. Jain, L. Poisson, J. Narang, L. Scarpace, M. Rosenblum, S. Rempel, T. Mikkelsen (2012)
Correlation of Perfusion Parameters with Genes Related to Angiogenesis Regulation in Glioblastoma: A Feasibility StudyAmerican Journal of Neuroradiology, 33
Jin Park, M. Lemmon (2012)
Occupy EGFR.Cancer discovery, 2 5
R. Verhaak, K. Hoadley, E. Purdom, V. Wang, Y. Qi, M. Wilkerson, C. Miller, L. Ding, Todd Golub, J. Mesirov, Gabriele Alexe, M. Lawrence, Michael O’Kelly, P. Tamayo, B. Weir, S. Gabriel, W. Winckler, Supriya Gupta, L. Jakkula, H. Feiler, J. Hodgson, C. James, J. Sarkaria, C. Brennan, A. Kahn, P. Spellman, R. Wilson, T. Speed, J. Gray, M. Meyerson, G. Getz, C. Perou, D. Hayes (2010)
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.Cancer cell, 17 1
Elana Tykocinski, Ryan Grant, G. Kapoor, J. Krejza, Leif-Erik Bohman, Tim Gocke, S. Chawla, C. Halpern, J. Lopinto, E. Melhem, D. O’Rourke (2012)
Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma.Neuro-oncology, 14 5
R. Barajas, J. Rubenstein, J. Chang, Jimmy Hwang, S. Cha (2010)
Diffusion-Weighted MR Imaging Derived Apparent Diffusion Coefficient Is Predictive of Clinical Outcome in Primary Central Nervous System LymphomaAmerican Journal of Neuroradiology, 31
T. Kreisl, Katharine Mcneill, J. Sul, F. Iwamoto, J. Shih, H. Fine (2012)
A phase I/II trial of vandetanib for patients with recurrent malignant glioma.Neuro-oncology, 14 12
W. Pope, Leili Mirsadraei, A. Lai, Ascia Eskin, J. Qiao, Hyun Kim, B. Ellingson, P. Nghiemphu, Samir Kharbanda, Robert Soriano, Stan Nelson, William Yong, Heidi Phillips, T. Cloughesy (2012)
Differential Gene Expression in Glioblastoma Defined by ADC Histogram Analysis: Relationship to Extracellular Matrix Molecules and SurvivalAmerican Journal of Neuroradiology, 33
H. Phillips, S. Kharbanda, Ruihuan Chen, W. Forrest, R. Soriano, Thomas Wu, A. Misra, J. Nigro, H. Colman, L. Soroceanu, P. Williams, Z. Modrušan, B. Feuerstein, K. Aldape (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.Cancer cell, 9 3
M. Prados, Susan Chang, N. Butowski, R. DeBoer, R. Parvataneni, Hannah Carliner, P. Kabuubi, J. Ayers-Ringler, J. Rabbitt, M. Page, A. Fedoroff, P. Sneed, Mitchel Berger, M. McDermott, A. Parsa, S. Vandenberg, C. James, K. Lamborn, D. Stokoe, D. Haas-Kogan (2009)
Phase II study of erlotinib plus temozolomide during and after radiation therapy in patients with newly diagnosed glioblastoma multiforme or gliosarcoma.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 4
A. Brandes, E. Franceschi, A. Tosoni, M. Hegi, R. Stupp (2008)
Epidermal Growth Factor Receptor Inhibitors in Neuro-oncology: Hopes and DisappointmentsClinical Cancer Research, 14
R. Barajas, J. Phillips, R. Parvataneni, A. Molinaro, E. Essock-Burns, G. Bourne, A. Parsa, M. Aghi, M. McDermott, M. Berger, S. Cha, Susan Chang, S. Nelson (2012)
Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.Neuro-oncology, 14 7
Guillem Ramis, Elena Thomàs-Moyà, S. Mattos, José Rodríguez, Priam Villalonga (2012)
EGFR Inhibition in Glioma Cells Modulates Rho Signaling to Inhibit Cell Motility and Invasion and Cooperates with Temozolomide to Reduce Cell GrowthPLoS ONE, 7
W. Pope, Hyun Kim, J. Huo, J. Alger, Matthew Brown, D. Gjertson, Victor Sai, J. Young, L. Tekchandani, T. Cloughesy, P. Mischel, A. Lai, P. Nghiemphu, S. Rahmanuddin, J. Goldin (2009)
Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment.Radiology, 252 1
M. Ronellenfitsch, D. Brucker, M. Burger, S. Wolking, F. Tritschler, J. Rieger, W. Wick, M. Weller, J. Steinbach (2009)
Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.Brain : a journal of neurology, 132 Pt 6
M. Diehn, C. Nardini, David Wang, S. McGovern, M. Jayaraman, Yu Liang, K. Aldape, S. Cha, M. Kuo (2008)
Identification of noninvasive imaging surrogates for brain tumor gene-expression modulesProceedings of the National Academy of Sciences, 105
M. Castillo, J. Smith, L. Kwock, K. Wilber (2001)
Apparent diffusion coefficients in the evaluation of high-grade cerebral gliomas.AJNR. American journal of neuroradiology, 22 1
M. Bruzzone, M. Eoli, V. Cuccarini, M. Grisoli, L. Valletta, G. Finocchiaro (2009)
Genetic signature of adult gliomas and correlation with MRI featuresExpert Review of Molecular Diagnostics, 9
Krister Barkovich, S. Hariono, A. Garske, Jie Zhang, Jimmy Blair, Q. Fan, K. Shokat, T. Nicolaides, W. Weiss (2012)
Kinetics of inhibitor cycling underlie therapeutic disparities between EGFR-driven lung and brain cancers.Cancer discovery, 2 5
K. Kono, Y. Inoue, K. Nakayama, M. Shakudo, M. Morino, K. Ohata, K. Wakasa, R. Yamada (2001)
The role of diffusion-weighted imaging in patients with brain tumors.AJNR. American journal of neuroradiology, 22 6
Bryan Choi, G. Archer, Duane Mitchell, A. Heimberger, R. McLendon, D. Bigner, J. Sampson (2009)
EGFRvIII‐Targeted Vaccination Therapy of Malignant GliomaBrain Pathology, 19
R. Young, Ajay Gupta, A. Shah, J. Graber, Zhigang Zhang, Weiji Shi, A. Holodny, A. Omuro (2011)
Potential utility of conventional MRI signs in diagnosing pseudoprogression in glioblastomaNeurology, 76
N. Bulakbaşı, I. Guvenc, O. Onguru, E. Erdoḡan, C. Tayfun, T. Ucoz (2004)
The Added Value of the Apparent Diffusion Coefficient Calculation to Magnetic Resonance Imaging in the Differentiation and Grading of Malignant Brain TumorsJournal of Computer Assisted Tomography, 28
J. Schlegel, A. Merdes, G. Stumm, Fritz Albert, M. Forsting, N. Hynes, M. Kiessling (2007)
Amplification of the epidermal‐growth‐factor‐receptor gene correlates with different growth behaviour in human glioblastomaInternational Journal of Cancer, 56
Xin Wang, A. Schneider (2010)
HIF-2alpha-mediated activation of the epidermal growth factor receptor potentiates head and neck cancer cell migration in response to hypoxia.Carcinogenesis, 31 7
D. Haas-Kogan, M. Prados, T. Tihan, D. Eberhard, N. Jelluma, Nils Arvold, R. Baumber, K. Lamborn, A. Kapadia, M. Malec, M. Berger, D. Stokoe (2005)
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.Journal of the National Cancer Institute, 97 12
D. Hamstra, C. Galbán, C. Meyer, T. Johnson, P. Sundgren, C. Tsien, T. Lawrence, L. Junck, David Ross, A. Rehemtulla, B. Ross, T. Chenevert (2008)
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 20
Eun Lee, K. terBrugge, D. Mikulis, D. Choi, J. Bae, Seon-Kyu Lee, S. Moon (2011)
Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions.AJR. American journal of roentgenology, 196 1
J. Rieger, O. Bähr, K. Müller, K. Franz, J. Steinbach, E. Hattingen (2010)
Bevacizumab-induced diffusion-restricted lesions in malignant glioma patientsJournal of Neuro-Oncology, 99
A. Lai, S. Kharbanda, P. Moftakhar, S. Lalaezari, W. Yong, W. Pope (2012)
ORIGINAL RESEARCH Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation, and Survival in Glioblastoma
I. Naqa, P. Grigsby, A. Apte, E. Kidd, E. Donnelly, D. Khullar, S. Chaudhari, Deshan Yang, M. Schmitt, R. Laforest, W. Thorstad, J. Deasy (2009)
Exploring feature-based approaches in PET images for predicting cancer treatment outcomesPattern recognition, 42 6
M. Halatsch, U. Schmidt, J. Behnke-Mursch, A. Unterberg, C. Wirtz (2006)
Epidermal growth factor receptor inhibition for the treatment of glioblastoma multiforme and other malignant brain tumours.Cancer treatment reviews, 32 2
B. Moffat, T. Chenevert, T. Lawrence, C. Meyer, T. Johnson, Q. Dong, C. Tsien, S. Mukherji, D. Quint, S. Gebarski, P. Robertson, L. Junck, A. Rehemtulla, B. Ross (2005)
Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.Proceedings of the National Academy of Sciences of the United States of America, 102 15
Leland Hu, J. Eschbacher, J. Heiserman, A. Dueck, W. Shapiro, Seban Liu, J. Karis, Kris Smith, S. Coons, P. Nakaji, R. Spetzler, B. Feuerstein, J. Debbins, L. Baxter (2012)
Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survivalNeuro-Oncology, 14
K. Kesavabhotla, C. Schlaff, B. Shin, Lynn Mubita, R. Kaplan, A. Tsiouris, S. Pannullo, P. Christos, E. Lavi, R. Scheff, J. Boockvar (2012)
Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma.Journal of experimental therapeutics & oncology, 10 1
Ajay Gupta, R. Young, S. Karimi, S. Sood, Zhigang Zhang, Q. Mo, P. Gutin, A. Holodny, A. Lassman (2011)
Isolated Diffusion Restriction Precedes the Development of Enhancing Tumor in a Subset of Patients with GlioblastomaAmerican Journal of Neuroradiology, 32
BACKGROUND AND PURPOSE: Epidermal growth factor receptor amplification is a common molecular event in glioblastomas. The purpose of this study was to examine the potential usefulness of morphologic and diffusion MR imaging signs in the prediction of epidermal growth factor receptor gene amplification status in patients with glioblastoma. MATERIALS AND METHODS: We analyzed pretreatment MR imaging scans from 147 consecutive patients with newly diagnosed glioblastoma and correlated MR imaging features with tumor epidermal growth factor receptor amplification status. The following morphologic tumor MR imaging features were qualitatively assessed: 1) border sharpness, 2) cystic/necrotic change, 3) hemorrhage, 4) T2-isointense signal, 5) restricted water diffusion, 6) nodular enhancement, 7) subependymal enhancement, and 8) multifocal discontinuous enhancement. A total of 142 patients had DWI available for quantitative analysis. ADC maps were calculated, and the ADC mean , ADC min , ADC max , ADC ROI , and ADC ratio were measured. RESULTS: Epidermal growth factor receptor amplification was present in 60 patients (40.8%) and absent in 87 patients (59.2%). Restricted water diffusion correlated with epidermal growth factor receptor amplification ( P = .04), whereas the other 7 morphologic MR imaging signs did not ( P > .12). Quantitative DWI analysis found that all ADC measurements correlated with epidermal growth factor receptor amplification, with the highest correlations found with ADC ROI ( P = .0003) and ADC mean ( P = .0007). CONCLUSIONS: Our results suggest a role for diffusion MR imaging in the determination of epidermal growth factor receptor amplification status in glioblastoma. Additional work is necessary to confirm these results and isolate new imaging biomarkers capable of noninvasively characterizing the molecular status of these tumors. ABBREVIATIONS: EGFR epidermal growth factor receptor GRE gradient recalled-echo
American Journal of Neuroradiology – American Journal of Neuroradiology
Published: Dec 1, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.